Innokylin provides tailor-made BD, licensing, financing and management consulting services to clients in the healthcare industry.

Headquartered in Hong Kong, with partners and teams in Shanghai (CN), Princeton (US) and Sydney (AUS), our firm supports high-potential Chinese biotech or med tech companies to go global. We also support the cutting edge products and solutions to enter into the Chinese market by partnering with the leading players in the region.

We are honoured to support pharma/bio-tech, medical device, IVDs and life sciences clients across the US, Europe, Australia, New Zealand, Southeast Asia and the Middle East.

Our elite partners were all ex-C-suite executives from top multinational pharmaceutical and medical device corporations. We all have over 20+ years’  international and/or domestic listed companies’ leadership experiences. We have intensive experience in business development, licensing, equity and debt financing, strategic and operational management, product commercialization, financial and internal control management, mergers and acquisitions.